In contrast, in glioblastoma (GBM), ABLIM1 acts as a tumor suppressor, where its overexpression is associated with reduced tumor size and improved patient survival (28), implicating the diverse role of ABLIM1 in different cancer context. This evidence concerns the gene ABLIM1 and glioblastoma.